Exhibit at the TSP 2026 Annual Meeting!
Why Should You Exhibit?
Largest gathering of board-certified pathologists * State leader in providing pathology-related CME program * Remain competitive in the market * Show your support for the field of pathology * Generate business leads from 200+ meeting attendees through website and conference exposure
REGISTER TODAY - 2026 EXHIBIT SHOW!
Questions about the TSP 2026 Annual Meeting?
Contact: [email protected]
THANK YOU TO OUR 2026 ANNUAL MEETING EXHIBITORS & SPONSORS
PLATINUM
AstraZeneca is a global, science-led, patient-focused pharmaceutical company. AstraZeneca's Precision Medicine Team's mission is to help you navigate the ever-expanding landscape of precision medicine. We're committed to helping you identify the right patients appropriate for biomarker testing to help ensure they receive the right treatment at the right time.
Contact: Brittnie Berry; [email protected]; (903) 399-5730
GOLD
Contact: Royce Spain; [email protected]; Ph: (214) 514-3232
With more than 240 subspecialty expert pathologists, PathGroup provides comprehensive anatomic, clinical and molecular pathology services, using the latest advancements in digital pathology an AI.
Contact: Jeremy Neff; [email protected]; (615) 509-1860
SILVER
Caris Life Sciences® is a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and unravel the molecular complexity of disease.
Contact: Reshma Adabi; [email protected]; Ph: (480) 318-7278
Fulgent is a technology-based company focused on transforming care. Our Fulgent Oncology product offerings include comprenhensive genomic profiling for both solid tumors and hematologic malignancies, hereditary cancer testing, and a variety of anatomic pathology services.
Contact: Joey Quach; [email protected]
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.
Contact: Rose Marie Zarrillo; [email protected]; Ph: (732) 594-0493
MSN Healthcare Solutions provides comprehensive pathology billing and practice management services. Practices may report MIPS measures through MSN's CMS-approved Qualified Clinical Data Registry (QCDR).
Contact: Chris Heimerl; [email protected]; Ph: (303) 809-3210
EXHIBITORS
Agilent Technologies
APS Medical Billing
(Contact: Brian Tetkowski)
Biocartis
(Contact: Doug Hebert)
Caris Life Sciences
Cleveland Clinic Laboratories
(Contact: Matt Pfleghaar)
CorePath Laboratories
(Contact: Curtis Loos)
Elea.health - The Pathology Operating System
Evident Scientific MIS
Grundium
(Contact: Todd Vanden Branden or Mark Thompson)
Guardant Health
Health Prime
HiPatho
(Contact: Limin Yu)
Hologic
(Contact: Christina Davis)
Interpace Diagnostics
(Contact: Amy Clark)
Johnson and Johnson
KUBTEC Medical
(Contact: Arpit Soni)
MedAR
Medusind
(Contact: Samuel Brown)
Michigan Medicine Laboratories
(Contact: Steve Gregg)
Mikroscan
(Contact: Lonnie Speir)
Motic Digital Pathology
NeoGenomics, Inc.
Novopath
(Contact: Scott Baruch)
Roche Diagnostics Corporation
(Contact: Samuel Judd and Dr. Joe Barrera)
Sakura Finetek USA
(Contact: Louis Perez)
Techcyte
(Contact: Ashley Monsia)
TELCOR
(Contact: Austin Martz, Senior Account Executive)
Veracyte
Vitro Laboratories
(Contact: Tim Christenson)
Voice Products
(Contact: Megan Wright)
|
